The new three-gene signature provided the greatest overall net benefit to trigger an intervention for definite or probable viral infection, whereas CRP provided the greatest overall net benefit to trigger an intervention for definite or probable bacterial infection (figure 4). The gene discussed is CRP; the disease is viral infectious disease.